Ledger.Open graph →
SEC Form D · filed June 10, 2020

BioLineRx Ltd

Offering
$9.0M
Sold
$9.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MODI'IN, L3
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (33)

Mali A. Zeevi · Modi'in, L3ExecAvraham J. Molcho · Modi'in, L3DirectorRaphael J. Hofstein · Modi'in, L3DirectorSandra J. Panem · Modi'in, L3DirectorNurit J. Benjamini · Modi'in, L3DirectorElla A. Sorani · Modi'in, L3ExecPhilip A. Serlin · Modi'in, L3ExecBarbara J. Bormann · Modi'in, L3DirectorMichael J. Anghel · Modi'in, L3DirectorAbi A. Vainstein-Haras · Modi'in, L3ExecAharon Schwartz · Modi'in, L3DirectorDavid Lowe · WALNUT CREEK, CADirectorTony Broglio · WALNUT CREEK, CADirectorRobert Slater · Cincinnati, OHDirectorJean-Louis Lelogeais · Cambridge, MADirectorZachary A. Mason · Fairbanks, AKExecMichael Hiles · Cincinnati, OHDirectorRandolph Cohen · Cambridge, MAExecJames J. Zenni, Jr · New York, NYDirectorJohn Bentley · Cincinnati, OHExecWilliam H. Winn, Jr · IRVINE, CADirectorMel Deane · WALNUT CREEK, CAExecNicole Cox · Denver, CODirectorAaron Stachel · Denver, COExecShannon Erley · Denver, CODirectorJessie Dixon · Denver, CODirectorHilmer Robert · Salt Lake City, UTExecWai Keng M. Kwok · Singapore, U0DirectorJason Roos · New York, NYDirectorJohn Feagin · Braselton, GAExecJody Flaws · Grand Cayman, Cayman IslandsDirectorArctis Management Cayman Limited · Grand Cayman, Cayman IslandsDirectorLeo Kassam · Grand Cayman, Cayman IslandsExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗